Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Peripheral Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00019890
What this trial is testing

Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00910650
What this trial is testing

Study of Gene Modified Immune Cells in Patients With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
Jonsson Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00516295
What this trial is testing

Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma

Who this might be right for
Ewing Sarcoma of BoneExtraosseous Ewing SarcomaPeripheral Primitive Neuroectodermal Tumor+1 more
National Cancer Institute (NCI) 7
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Not applicableStudy completedNCT01210209
What this trial is testing

Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives

Who this might be right for
Sarcoma
Institut Curie 350
Not applicableEnrolling By InvitationNCT06703944
What this trial is testing

Risk Model for Metastasis Detection of Neuroblastoma

Who this might be right for
Neuroblastoma (NB)PrognosisBone Marrow Metastasis+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 500
Testing effectiveness (Phase 2)Looking for participantsNCT06450041
What this trial is testing

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 62
Not applicableStudy completedNCT01121419
What this trial is testing

The Role of IMP3 Expression in Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
National Taiwan University Hospital
Early research (Phase 1)Study completedNCT01208454
What this trial is testing

Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma

Who this might be right for
Localized Unresectable NeuroblastomaRecurrent NeuroblastomaRegional Neuroblastoma+2 more
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT01158300
What this trial is testing

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 28
Early research (Phase 1)Study completedNCT03236857
What this trial is testing

The Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

Who this might be right for
MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)+2 more
AbbVie 143
Early research (Phase 1)Active Not RecruitingNCT04106219
What this trial is testing

LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Eli Lilly and Company 71
Testing effectiveness (Phase 2)Study completedNCT00330421
What this trial is testing

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Who this might be right for
Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorMetastatic OsteosarcomaRecurrent Adult Soft Tissue Sarcoma+6 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)WithdrawnNCT04909515
What this trial is testing

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.

Who this might be right for
Neuroblastoma
Y-mAbs Therapeutics
Large-scale testing (Phase 3)Looking for participantsNCT03126916
What this trial is testing

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Who this might be right for
GanglioneuroblastomaGanglioneuroblastoma, NodularNeuroblastoma
Children's Oncology Group 750
Very early researchLooking for participantsNCT07493447
What this trial is testing

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Who this might be right for
MeningiomaGlioblastomaAcoustic Neuroma+2 more
Eben Rosenthal 30
Testing effectiveness (Phase 2)Study completedNCT00030264
What this trial is testing

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
Children's Hospital of Philadelphia 23
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Not applicableUnknownNCT04004377
What this trial is testing

Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised

Who this might be right for
Acoustic Neuroma
University Hospital, Bordeaux 200
Large-scale testing (Phase 3)Ended earlyNCT01875653
What this trial is testing

Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma

Who this might be right for
Stage IV MelanomaStage III Melanoma
Lisata Therapeutics, Inc. 4
Next Page